Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Deficiency) (Details 4)

v3.7.0.1
Stockholders' Equity (Deficiency) (Details 4) - $ / shares
12 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Number of Options    
Number of options unvested, Beginning balance 141,016 180,590
Number of unvested options granted 264,600 177,500
Number of options, Vested (87,583) (147,293)
Number of options, Forfeited   (65,093)
Number of options, Cancelled   (4,688)
Number of options unvested, Ending balance 318,033 141,016
Weighted Average Exercise Price    
Weighted average exercise price unvested, Beginning balance $ 3.17 $ 3.80
Weighted average exercise price unvested, Granted 4.82 3.96
Weighted average exercise price unvested, Vested 4.68 3.71
Weighted average excercise price unvested, Forfeited   3.67
Weighted average exercise price unvested, Cancelled   4.20
Weighted average exercise price unvested, Ending balance 4.81 3.17
Weighted Average Grant Date Fair Value    
Weighted average grant date fair value, unvested, Beginning balance 1.73 1.64
Weighted average grant date fair value, unvested, Granted 2.61 2.24
Weighted average grant date fair value, unvested, Vested 2.48 2.09
Weighted average grant date fair value, unvested,Forfeited   0.91
Weighted average grant date fair value, unvested, Cancelled   2.28
Weighted average grant date fair value, unvested, Ending balance $ 2.57 $ 1.73